Related Experiment Videos
[Heat stroke and fulminans hepatitis: is MARS system relevant?]
M Biais1, K Nouette-Gaulain, A Lelias
1Département d'anesthésie-réanimation I, CHU Pellegrin, 146, rue Leo-Saignat, 33076 Bordeaux cedex, France.
Annales Francaises D'Anesthesie Et De Reanimation
|August 16, 2005
Summary
Exertional heat stroke (EHS) can cause acute liver failure. Molecular Adsorbent Recirculating System (MARS) therapy improved liver function, avoiding the need for liver transplantation in a patient with EHS-induced liver failure.
Area of Science:
- Hepatology
- Critical Care Medicine
- Toxicology
Background:
- Exertional heat stroke (EHS) is a severe hyperthermia condition.
- Acute liver failure is a known complication of EHS.
- Liver transplantation is a potential treatment for EHS-induced liver failure.
Observation:
- A 58-year-old patient developed acute liver failure following EHS.
- The patient was evaluated for liver transplantation.
- Molecular Adsorbent Recirculating System (MARS) therapy was initiated.
Findings:
- Three sessions of MARS therapy led to progressive improvement in liver function.
- The need for liver transplantation was averted.
- The patient achieved complete recovery.
Implications:
- MARS therapy may be a viable alternative to liver transplantation in EHS-induced acute liver failure.
- This case highlights the potential benefit of MARS in managing severe hyperthermia complications.
- Further research into MARS for critical care settings is warranted.